Collisional solute release from thermally activated lipid particles

Drug Development and Industrial Pharmacy

Volumn 35, Issue 1, 2009, Pages 12-18

  Zeng, Pengyun ^a   Mahlberg, Jeffrey ^a   Wiedmann, Timothy Scott ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Collision theory; Diphenylhexatriene; Fluorescence; Myristyl alcohol; Thermal release

Indexed keywords

1,6 DIPHENYL 1,3,5 HEXATRIENE; DODECYL SULFATE SODIUM; MYRISTYL ALCOHOL; SOLID LIPID NANOPARTICLE;

ARTICLE; COLLISIONALLY ACTIVATED DISSOCIATION; CONCENTRATION RESPONSE; DESICCATION; DRUG DELIVERY SYSTEM; DRUG RELEASE; HEATING; MICELLE; NEBULIZATION; PARTICLE SIZE; TEMPERATURE DEPENDENCE;

CHEMISTRY, PHARMACEUTICAL; DIPHENYLHEXATRIENE; FATTY ALCOHOLS; HOT TEMPERATURE; MICELLES; NANOPARTICLES; SODIUM DODECYL SULFATE; SURFACE-ACTIVE AGENTS; TIME FACTORS;

EID: 56749183580     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.1080/03639040802130087     Document Type: Article

References (22)

1. Aoki, H., Kakinuma, K., Morita, K., Kato, M., Uzuka, T., Igor, G., Takahashi, H., Tanaka, R. (2004). Therapeutic efficacy of targeting chemotherapy using local hyperthermia and thermosensitive liposome: Evaluation of drug distribution in a rat glioma model. Int J Hyperthermia, 20(6), 595-605.
2. Bondarev, S. L., & Bachilo, S. M. (1990). Solvent and temperature effects on fluorescence and absorption from the S1 states in diphenylpolyenes. J. Appl. Spectrosc., 53(5), 1142-1147.
3. Chan, A. F., Evan, D. F., & Cussler, E. L. (1976). Explaining solubilization kinetics. AIChE J., 22(6), 1006-1012.
4. Epstein, M. B., & Ross, J. (1957). Solubility of lauryl alcohol in aqueous solutions of sodium lauryl sulfate. J. Phys. Chem., 61, 1578.
5. Evans, D. F., & Wennerström, H. (1999). The colloidal domain: Where physics, chemistry, biology, and technology meet. New York: Wiley-VCH.
6. Hitzman, C. J., Elmquist, W. F., Wattenberg, L. W., & Wiedmann, T. S. (2006). Development of a respirable, sustained release microcarrier for 5-fluorouracil I: In vitro assessment of liposomes, microspheres, and lipid coated nanoparticles. J Pharm Sci., 95(5), 1114-1126.
7. Jonstromer, M., Jonsson, M., & Lindman, B. (1991). Self-diffusion in nonionic surfactant-water systems. J. Phys. Chem., 95(8), 3293-3300.
8. Lao, L. L., & Ramanujan, R. V. (2004). Magnetic and hydrogel composite materials for hyperthermia applications. J. Mater. Sci. Mater. Med., 15(10), 1061-1064.
9. Ma, Z. N., Friberg, S. E., & Neogi, P. (1989). Single-component mass transfer in a cosurfactant-water-surfactant system. AIChE J., 35(10), 1678-1684.
10. Mehnert, W., & Mader, K. (2001). Solid lipid nanoparticles production, characterization and applications. Adv. Drug Deliv. Rev., 47, 165-169.
11. Moore, J. W., Pearson, R. G., & Frost, A. A. (1981). Kinetics and mechanism. New York: Wiley.
12. Needham, D., Anyarambhatla, G., Kong, G., & Dewhirst, M. W. (2000). A new temperature-sensitive liposome for use with mild hyperthermia: Characterization and testing in a human tumor xenograft model. Cancer Res., 60(5), 1197-1201.
13. Prudich, M. E., & Henry, J. D. (1978). The mechanisms of transfer of hydrophobic coated mineral matter particles from a hydrocarbon to an aqueous phase. AIChE J., 24(5), 788-795.
14. Stilbs, P. (1982). Fourier transform NMR pulsed-gradient spin-echo (FT-PGSE) self-diffusion measurements of solubilization equilibria in SDS solutions. J. Colloid Interface Sci., 87(2), 385-394.
15. Venkateswarlu, V., & Manjunath, K. (2004). Preparation, characterization and in vitro release kinetics of clozapine solid lipid nanoparticles. J. Control. Release, 95(3), 627-638.
16. Wiedmann, T. S., & Hitzman, C. J. (2004). Reflux drying of aerosols. J Aerosol Med., 17(4), 344-353.
17. Wissing, S. A., Kayser, O., & Muller, R. H. (2004). Solid lipid nanoparticles for parenteral drug delivery. Adv. Drug Deliv. Rev., 56(9), 1257-1272.
18. Wong, H. L., Bendayan, R., Rauth, A. M., Li, Y. Q., & Wu, X. Y. (2007). Chemotherapy with anticancer drugs encapsulated in solid lipid nanoparticles. Adv. Drug Deliv. Rev., 59, 491-504.
19. Xiang, Q. Y., Wang, M. T., Chen, F., Gong, T., Jian, Y. L., Zhang, Z. R., Huang, Y. (2007). Lung-targeting delivery of dexamethasone acetate loaded solid lipid nanoparticles. Arch. Pharm. Res., 30(4), 519-525.
20. Zara, G. P., Bargoni, A., Cavalli, R., Fundaro, A., Vighetto, D., & Gasco, M. R. (2002). Pharmacokinetics and tissue distribution of idarubicin-loaded solid lipid nanoparticles after duodenal administration to rats. J. Pharm. Sci., 91(5), 1324-1333.
21. Zara, G. P., Cavalli, R., Bargoni, A., Fundaro, A., Vighetto, D., & Gasco, M. R. (2002). Intravenous administration to rabbits of non-stealth and stealth doxorubicin-loaded solid lipid nanoparticles at increasing concentrations of stealth agent: pharmacokinetics and distribution of doxorubicin in brain and other tissues. J. Drug Target, 10(4), 327-335.
22. zur Muhlen, A., Schwarz, C., & Mehnert, W. (1998). Solid lipid nanoparticles (SLN) for controlled drug delivery-drug release and release mechanism. Eur. J. Pharm. Biopharm., 45(2), 149-155.